Marseille

France

1,518 total trials 666 recruiting

Filter these 1,518 trials by phase, condition, sponsor and more.

Open in Search →

Trail aiming to assess the safety and clinical activity of bemarituzumab + bevacizumab in advanced/metastatic gynecological cancer overexpre … Ended

2024-516724-33-00 9 Advanced/metastatic gynecological cancer overexpressing FGFR2b
LONG-TERM INTERVENTIONAL FOLLOW-UP STUDY UP TO 4 YEARS OF AGE OF CHILDREN WITH PRADER-WILLI SYNDROME INCLUDED IN THE OTBB3 CLINICAL TRIAL AN … Ended

2024-517925-25-00 4 prader-willi syndrome
PRODIGE 111 – DOMZIGAST A randomized phase II study evaluating FOLFIRI vs FOLFIRI plus Domvanalimab (anti-TIGIT) and Zimberelimab (anti-PD1) … Ended

2024-519258-35-00 4 stomach cancer
A trial to find out how well CVHNLC works at different dose levels and how safe it is in combination with pembrolizumab in patients with lun … Ended

2024-519651-28-00 1 metastatic squamous non-small cell lung cancer
A Study of Valemetostat Tosylate Plus Pembrolizumab versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations Ended

2024-519671-26-00 9 Advanced or Metastatic Non-Small Cell Lung Cancer
A study of lifileucel (tumor-infiltrating lymphocytes) in adults with advanced melanoma Ended

2025-522054-40-00 4 Previously treated advanced melanoma

Showing 1,513–1,518 of 1,518 trials